Abagovomab
N/A
Report date: 2022/07/19 16:22:54
Base Information
Drug NameAbagovomab
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCellcontrol Biomedical Laboratories
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMenarini GroupNational Cancer Institute
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia